Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2014-08-01Clinical Trial Update: Effect of an Inhaled Glucocorticoid-long-acting Beta Adrenergic Agonist on Endothelial Function in COPD [Phase 2]
A Phase 2 COPD trial evaluating an inhaled corticosteroid-long-acting beta-agonist on endothelial function has been withdrawn. The sponsor w…
-
FDA approval · 2014-07-31FDA Approved: STRIVERDI RESPIMAT — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved Striverdi Respimat (olodaterol inhalation spray) as an original application from Boehringer Ingelheim for the treatment of …
-
CLINICAL_TRIALS research · 2014-07-29Clinical Trial Update: Pursed-lips Breathing and Dynamic Hyperinflation [NA]
This document provides a clinical trial update indicating the study on pursed-lips breathing and dynamic hyperinflation in Chronic Obstructi…
-
CLINICAL_TRIALS research · 2014-07-25Clinical Trial Update: Assessment of Pulmonary Specialty Physicians' Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases
A completed clinical trial update reporting on a study that assesses how pulmonary specialists approach advanced care planning in patients w…
-
CLINICAL_TRIALS trial_result · 2014-07-23Clinical Trial Update: Effects of Nutritional Supplementation in Malnourished Patients in Stable COPD [Phase 4]
Phase 4 clinical trial update evaluating the effects of nutritional supplementation in malnourished patients with stable chronic obstructive…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: A Prescription-Event Monitoring (PEM) Study of Tiotropium
This document notes the completion of a Prescription-Event Monitoring study evaluating tiotropium for chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Inhaled Bronchodilator Association and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease
This clinical trial update reports on a completed study evaluating the relationship between inhaled bronchodilators and quality of life in p…
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial comparing safety and efficacy of Combivent HFA to Combivent (CFC) in chronic obstructive pulmonary disease has been terminated…
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom [Phase 4]
A Phase 4 trial evaluating the pharmacological effect of lysozyme for chronic obstructive pulmonary disease and asthma has completed. The st…
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: Music and Perceived Rate of Exertion [NA]
A completed clinical trial (NCT01833260) evaluated whether music affects perceived rate of exertion in patients with chronic obstructive pul…
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 trial comparing two doses of ipratropium bromide versus ATROVENT inhalation aerosol in adults with chronic obstructive pulmonary dis…
-
FDA approval · 2014-07-17FDA Approved: TUDORZA PRESSAIR — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for Tudorza Pressair (aclidinium bromide) submitted by Covis Pharma US, Inc.
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: After Discharge Management of Low Income Frail Elderly [NA]
A completed clinical trial update focusing on after-discharge management for low-income frail elderly patients with multiple chronic conditi…
-
CLINICAL_TRIALS withdrawal · 2014-07-17Clinical Trial Update: Evaluation of Remote Patient Monitoring.
A clinical trial evaluating remote patient monitoring for congestive heart failure and chronic obstructive pulmonary disease was withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Is it Necessary to Set External PEEP in AECOPD Patients [NA]
The clinical trial assessing whether external PEEP is necessary in acute exacerbations of chronic obstructive pulmonary disease has complete…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Comparison of Safety and Efficacy of Berodual® Administered Via the Respimat® Device With That Administered Via the Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial comparing safety and efficacy of Berodual delivered by the Respimat device versus a metered-dose inhaler in patients with chro…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition [Phase 3]
Phase 3 trial comparing Berodual Respimat with the Berodual MA Inhaler in patients with asthma, chronic obstructive pulmonary disease, or mi…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Respimat® Inhaler vs a Metered Dose Inhaler Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 clinical trial comparing the Respimat inhaler with a metered-dose inhaler using Berodual in patients with chronic obstructive pulm…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Berodual® Respimat® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease [Phase 3]
A Phase 3 trial comparing Berodual Respimat with a Metered Dose Inhaler in chronic obstructive pulmonary disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Ba253BINEB Compared to Ba253MDI (Metered Dose Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 trial comparing Ba253BINEB with Ba253MDI in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Ba253BINEB in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 clinical trial of Ba253BINEB in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS withdrawal · 2014-07-11Clinical Trial Update: Efficacy and Safety of Two Doses of Formoterol Fumarate MDI (PT005) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), Compared to Foradil® Aerolizer® as an Active Control [Phase 2]
Phase 2 trial evaluating two doses of formoterol fumarate metered-dose inhaler (PT005) versus Foradil Aerolizer in stable COPD was withdrawn…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHF
An observational study evaluating RSV-associated illness in adults with COPD and/or congestive heart failure has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry I [Phase 3]
Phase 3 trial evaluating BI 1744 CL (5 and 10 mcg) versus placebo on exercise endurance time in COPD patients; the study was completed and r…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry II [Phase 3]
A Phase 3 trial comparing BI 1744 CL (5 and 10 mcg) to placebo assessed exercise endurance time in chronic obstructive pulmonary disease; th…